Clinical Trials · NCT07767552
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Yanbing Li
- Enrollment
- 249
- Start date
- Sep 2026
- Locations
- 1 site, China
- Primary endpoint
- Proportion of Participants Achieving Normal Glucose Regulation (NGR) at Week 44